Valens Molecules Private Limited
Valens Molecules Private Limited is a Private Indian company incorporated in 1994 and based in Telangana, India. Valens Molecules Private Limited operates in Pharmaceuticals & Chemicals (NIC 24100) with authorized capital of —. RegisterKaro's Compliance Health Score for the company is 30/100 (grade F), reflecting a weak compliance posture.
Quick facts
Directors
LockedDirectors, DINs & appointment history for Valens Molecules Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
MCA Filings
Locked| Form | FY | Filed | Due | Delay | Status |
|---|---|---|---|---|---|
| AOC-4 | FY2024-25 | 30 Oct 2024 | 30 Oct 2024 | 0d | filed |
| MGT-7 | FY2024-25 | 20 Nov 2024 | 29 Nov 2024 | 0d | filed |
| AOC-4 | FY2023-24 | 30 Oct 2023 | 30 Oct 2023 | 0d | filed |
| MGT-7 | FY2023-24 | 22 Nov 2023 | 29 Nov 2023 | 0d | filed |
| AOC-4 | FY2022-23 | 30 Oct 2022 | 30 Oct 2022 | +2d | filed |
| MGT-7 | FY2022-23 | 23 Nov 2022 | 29 Nov 2022 | 0d | filed |
Full MCA filing history for Valens Molecules Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Charges
Locked| Charge ID | Holder | Amount | Created | Status |
|---|---|---|---|---|
| 607995562 | HDFC Bank Ltd(Bank) | ₹16.27 Cr | 27 Jan 2020 | Open |
| 676744783 | ICICI Bank Ltd(Bank) | ₹20.96 Cr | 19 Sep 2023 | Satisfied |
| 141140150 | State Bank of India(Bank) | ₹21.66 Cr | 27 Jan 2020 | Satisfied |
| 538144865 | ICICI Bank Ltd(Bank) | ₹14.39 Cr | 27 Jan 2019 | Satisfied |
| 614406944 | HDFC Bank Ltd(Bank) | ₹5.65 Cr | 12 Mar 2021 | Open |
Charge IDs, lenders & amounts for Valens Molecules Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Financial Performance
Locked| FY | Revenue | PAT | Net Worth | Total Assets | Employees |
|---|---|---|---|---|---|
| FY2024-25 | ₹15.55 Cr | ₹2.29 Cr | ₹15.57 Cr | ₹23.88 Cr | 348 |
| FY2023-24 | ₹12.13 Cr | ₹1.59 Cr | ₹6.88 Cr | ₹12.38 Cr | 187 |
| FY2022-23 | ₹13.45 Cr | ₹2.00 Cr | ₹9.27 Cr | ₹18.52 Cr | 251 |
| FY2021-22 | ₹8.96 Cr | ₹1.26 Cr | ₹5.26 Cr | ₹10.16 Cr | 229 |
Audited financials & ratios for Valens Molecules Private Limited.
- Financial Summary & Charts
- Income Statement, Balance Sheet, Cashflow
- Profitability, Liquidity & Growth Ratios
- Audited Financial Statement (AOC-4)
Detailed Financials
Locked| Line item | FY2024-25 | FY2023-24 | FY2022-23 | FY2021-22 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue from operations | ₹15.55 Cr | ₹12.13 Cr | ₹13.45 Cr | ₹8.96 Cr |
| Other income | ₹10.12 L | ₹9.13 L | ₹49.62 L | ₹23.53 L |
| Total income | ₹15.65 Cr | ₹12.22 Cr | ₹13.95 Cr | ₹9.20 Cr |
| Total expenses | ₹12.72 Cr | ₹10.19 Cr | ₹11.38 Cr | ₹7.59 Cr |
| Profit before tax | ₹2.98 Cr | ₹2.06 Cr | ₹2.60 Cr | ₹1.63 Cr |
| Profit / (Loss) after tax | ₹2.29 Cr | ₹1.59 Cr | ₹2.00 Cr | ₹1.26 Cr |
| Balance sheet | ||||
| Equity / Net worth | ₹15.57 Cr | ₹6.88 Cr | ₹9.27 Cr | ₹5.26 Cr |
| Borrowings | ₹2.95 Cr | ₹1.74 Cr | ₹1.99 Cr | ₹1.24 Cr |
| Current liabilities | ₹2.80 Cr | ₹2.51 Cr | ₹3.58 Cr | ₹2.93 Cr |
| Total liabilities | ₹8.31 Cr | ₹5.49 Cr | ₹9.25 Cr | ₹4.90 Cr |
| Current assets | ₹12.83 Cr | ₹6.75 Cr | ₹10.67 Cr | ₹4.42 Cr |
| Cash & equivalents | ₹4.40 Cr | ₹1.18 Cr | ₹1.38 Cr | ₹77.76 L |
| Total assets | ₹23.88 Cr | ₹12.38 Cr | ₹18.52 Cr | ₹10.16 Cr |
| Employees | 348 | 187 | 251 | 229 |
Audited financials & ratios for Valens Molecules Private Limited.
- Financial Summary & Charts
- Income Statement, Balance Sheet, Cashflow
- Profitability, Liquidity & Growth Ratios
- Audited Financial Statement (AOC-4)
Compounded Annual Growth Rate
Locked| Metric | Latest value | 1Y CAGR | 3Y CAGR | 5Y CAGR |
|---|---|---|---|---|
| Revenue | ₹15.55 Cr | +1.6% | +7.6% | +19.9% |
| Profit after Tax | ₹2.29 Cr | +13.6% | -0.8% | -1.0% |
| Net Worth | ₹15.57 Cr | +34.4% | +3.5% | +5.7% |
| Employees | 348 | -7.8% | +12.7% | +3.9% |
Audited financials & ratios for Valens Molecules Private Limited.
- Financial Summary & Charts
- Income Statement, Balance Sheet, Cashflow
- Profitability, Liquidity & Growth Ratios
- Audited Financial Statement (AOC-4)
Financial Ratios
Locked| FY | Revenue | PAT | PAT margin | Rev growth | ROE | ROA | D/E | Rev/emp |
|---|---|---|---|---|---|---|---|---|
| FY2024-25 | ₹15.55 Cr | ₹2.29 Cr | +14.74% | +25.40% | +14.72% | +9.60% | 0.19 | ₹4.47 L |
| FY2023-24 | ₹12.13 Cr | ₹1.59 Cr | +13.07% | +9.49% | +23.05% | +12.82% | 0.25 | ₹6.49 L |
| FY2022-23 | ₹13.45 Cr | ₹2.00 Cr | +14.89% | -12.78% | +21.62% | +10.82% | 0.21 | ₹5.36 L |
| FY2021-22 | ₹8.96 Cr | ₹1.26 Cr | +14.03% | +26.20% | +23.90% | +12.38% | 0.24 | ₹3.91 L |
Audited financials & ratios for Valens Molecules Private Limited.
- Financial Summary & Charts
- Income Statement, Balance Sheet, Cashflow
- Profitability, Liquidity & Growth Ratios
- Audited Financial Statement (AOC-4)
Cap Table & Shareholding
Locked| Category | Shareholders | Shares held | % |
|---|---|---|---|
| Promoters | 2 | 2,61,27,903 | 71.00% |
| Institutional Investors | 1 | 18,82,714 | 5.12% |
| Public & Others | 14 | 87,89,783 | 23.89% |
Promoter, institutional & public holding for Valens Molecules Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Peer Benchmark
50 peersEvents & timeline
1External data sources
7 plannedGSTIN Registrations
Per-state GSTINs + GSTR-1/3B filing cadence + turnover bracket. PAN-keyed scrape.
MSME Payment Delays
Half-yearly disclosure of payments delayed beyond 45 days to MSME suppliers.
Related Party Transactions
Counterparty, nature, transaction value. Inter-company loans, sales, royalty.
Credit Ratings
Long-term + short-term ratings, with rationale on rating actions.
Trademarks
Applied, registered, opposed. Class numbers + status.
Patents
Applications and grants. Inventor names + filing dates.
Legal Cases
Ongoing + past litigations the entity is party to.
Each source is wired as a separate ingestion adapter behind the scraper. Live status flips per CIN as records land.